Award
National Institute on Drug Abuse 1DP2DA060600-01
Taking Our Shot: Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV
Recipient
University of California, San Francisco
Award Amount
$2,460,000.00
Ceiling
$2,460,000.00
Awarded
June 10, 2024
Identifier
1DP2DA060600-01
This award funds a study at UCSF to evaluate extended-release naltrexone for opioid overdose prevention among stimulant users at risk of or living with HIV, combining overdose prevention with HIV care.
Description
A randomized controlled trial to test an innovative approach to opioid overdose prevention using injectable, long-acting opioid blocking medication (naltrexone) combined with injectable HIV prevention or treatment medication, aimed at people living with or at risk of HIV who use stimulants. The study integrates overdose prevention with HIV care.